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SUMMARY – In the context of modern scientific and technological developments in biomedicine 
and health care, and the potential consequences of their application on humans and the environment, 
Potter’s global bioethics concept resurfaces. By actualizing Potter’s original thoughts on individual 
bioethical issues, the universality of two of his books, which today represent the backbone of the 
world bioethical literature, “Bioethics – Bridge to the Future” and “Global Bioethics: Building on the 
Leopold Legacy”, is emphasized. Potter’s global bioethics today can legitimately be viewed as a bridge 
between clinical personalized ethics on the one hand and ethics of public health on the other.
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Introduction
In the context of modern science and technology 
but also the society as a whole, it is legitimate to ask 
what is the place and role of bioethics? Is it just an-
other segment of the historical heritage in medicine? 
Or a legacy of an exciting time when every scientific 
and technological change could keep up with social 
change? Does the society today (at the global level) 
have the power to react to changes as it was the case in 
the 1960s and 1970s, in the vortex of the 20th century 
scientific revolution?
Do we really need bioethics? If so, what sort? Tra-
ditional principalistic1, bioethics focused on the vir-
tues2, global3, integrative4 or specialized5, American 
or European6...? Be as it may, peeling off the layers 
of its content leads to its first and original definition, 
which today, more than ever, comes to the fore – that 
bioethics is a bridge7. Bioethics attempts to connect, 
reconcile and unite the interest of the individual and 
the society, the researcher and the financier, the pa-
tient and the doctor, the man (his moral values) and 
Earth (the environment)… Today, more than ever, 
it is necessary to go back to the roots and recall the 
way in which Professor Van Rensselaer Potter II en-
visioned bioethics, not as a science but as engaging in 
and leading a life of humility, responsibility and abil-
ity8... Do we have strength for it today and can we be 
the “knights of good science”...?
“God Committee” and “Potter’s Bridge”
Bioethics was created as a social movement and 
developed into a scientific discipline as a reaction to 
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the great scientific and technological achievements 
in medicine. Historians of bioethics usually refer to it 
when analyzing major bioethical scandals (the Tuskeg-
ee Syphilis Study, Willowbrook, etc.)9, but it is neces-
sary to recall the story of the “God Committee”9-11. It 
shows that science without humanity is powerless and 
that professionalism without ethics is insufficient.
In 1961, thanks to Belding H. Scribner (1921-2003), 
the “father” of kidney dialysis, John Myers, the first pa-
tient to be sent to dialysis, was hospitalized in the Uni-
versity Hospital in Seattle. At the time, the capacities of 
the Center for Dialysis could receive up to five patients 
a year, while the needs were thousands of times higher. 
The problem of the selection of patients emerged, and 
the selection in reality meant life or death. The so called 
“3WHO” question was raised, i.e. who would live, who 
would die, and who would make that decision? Under 
the given circumstances, the idea emerged of  establish-
ing a multidisciplinary body that patients themselves, 
candidates for dialysis, termed the “God Committee” 
due to the nature of decisions it made. The committee 
consisted of nine members: banker, priest, lawyer, state 
official, trade unionist, housewife, and a three-member 
medical board. The selection criteria were age, gender, 
social status, income, property, emotional stability, 
education, employment, previous contribution to the 
community, expected perspectives, recommendations, 
etc. The choice literally represented life, non-selection 
of death9-11. This is one of many examples how clini-
cal ethical dilemmas represent clinical problems where 
all potential solutions might require violation of some 
moral rule12.
The New York Times published a brief informa-
tion on the committee which decided in the Cen-
ter for Dialysis of the University Hospital in Seattle 
which of the patients would be dialyzed, i.e. which 
of the patients would live and which would die. Life’s 
journalist Shana Alexander (1925-2005) read this line 
in the newspaper and decided to write a story about 
the so-called “God Committee”. She moved from 
New York to Seattle where she stayed for six months, 
and wrote the article “They Decide Who Lives, Who 
Dies: Medical Miracle Puts a Moral Burden on a 
Small Committee”, whose publication date in Life 
magazine, on November 9, 1962, is according to some 
of the world’s leading bioethicists considered as the 
beginning of bioethical history13. 
The article provoked strong public reaction and a 
lot of harsh criticism. A heated bioethical debate was 
raised about the issue of justice in the use of medical 
technology and ethical implications of decision on its 
availability to individual patients. This moment repre-
sents the beginning of the interest and public inform-
ing about topics of bioethical content, especially in 
medicine, for fear of possible abuses. It is precisely the 
“social commotion” that led to the raising of bioethical 
topics to the academic level: scientific and technical 
literature began to be written, events and conferences 
were organized, centers were established, institutes 
and courses were proposed, etc.14.
As public reaction to these great scientific and 
technological advances, which would since then mark 
every moment of the future of medicine, i.e. from to-
day’s perspective, contemporary medicine, there ap-
peared a paradox: a never greater faith in progress 
– techno-optimism, and a never greater fear of its con-
sequences – techno-pessimism. That same year, when 
the first “artificial kidney” was activated, on the other 
side of the United States, this time not a journalist but 
a scientist was tortured by this very question: are we 
allowed to do all we are capable of, and where are the 
limits of action8? 
Van Rensselaer Potter II was invited to speak as a 
former student at the South Dakota State University 
in 1962, when the centenary of the inauguration cer-
emony for the grant allocation system was celebrated 
(in 1862 Abraham Lincoln signed the Morrill Act, and 
the University was one of the Land Grant Colleges – 
colleges established on granted land)8,15,16. Potter was 
invited as one of the leading researchers in the field of 
oncology. At that point, he had been developing for 
over 20 years the methods to determine the amount of 
different enzymes in rat liver transplant tumors aris-
ing from about 40 different primary tumors induced 
by certain chemicals added to the food of rats. He ex-
pressed his idea of  a halted differentiation through the 
hypothesis: “Oncogenesis is a blocked ontogenesis”17-
21. Also, he was involved in two projects during World 
War II and the Korean War, i.e. research of irrevers-
ible shock and adaptation to high altitudes.
For some reason, at this meeting he decided to talk 
about something completely different, something that 
was on his mind for a while, but what he had never 
publicly verbalized before. What worried him at the 
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time was the question of progress and in which direc-
tion all that materialistic scientific and technological 
progress was leading the Western culture. He set his 
mind to something that for him, according to his own 
words, had become the purpose of bioethics: “the at-
tempt to answer the question facing humanity – what 
kind of future awaits us and do we have a choice? This 
is how bioethics became a concept that demanded a 
discipline that would lead the humanity and form a 
bridge to the future”15,16.
Indeed, it all started with a lecture from 1962 
whose aim was to point to socially contradictory ideas 
about progress. The title of the lecture was: “Bridge 
to the Future: The Concept of Human Progress”. The 
metaphor of a “bridge to the future” had been used 
nine years before the word bioethics was created and 
defined8,15,16.* 
Potter’s Bioethics
Van Rensselaer Potter II was born in 1911 in 
South Dakota, and received his degree in chemistry 
and biology in 1933. He devoted himself to the study 
of cancer and spent most of his scientific career at the 
University of Wisconsin in Madison as a Professor of 
Oncology. He was president of the American Associ-
ation for Cancer Research, and was member of several 
national and international scientific institutions, in-
cluding the American Academy of Arts and Sciences. 
He retired in 1982 as Professor Emeritus of Oncol-
ogy, but focused in the following years exclusively on 
bioethics and the improvement of his ideas from 1971. 
He founded, among other things, the Global Bioeth-
ics Network. He died in 200125.
In 1970, he wrote the article “Bioethics, the Sci-
ence of Survival”, which he published in the journal 
Perspective Biology and Medicine. Here he used the 
term bioethics for the first time, coined from two words 
of Greek origin: bios = biological knowledge that ex-
pands and ethikos = system of human values26. A year 
later, he published the book “Bioethics – Bridge to the 
Future”. He used the term “bridge” as a symbol for a 
new scientific discipline, which would represent a link 
between natural sciences and humanities, as well as 
between biological science and ethics7. Professor Luka 
Tomašević has best described the importance of this 
book in the preface to the Croatian edition: “This book 
by V.R. Potter II is one of the most important and 
best-known books written in the last century. As he 
was writing it, the author probably was not aware that 
he was writing a book that would be the beginning 
of something new, i.e. of a new science: bioethics”27. 
With this book and numerous lectures held during 
1975, Potter warned that “the moral problem arises 
because medical science has achieved partial success 
in organ maintenance without person maintenance...” 
He believed that at present time, medical ethicists 
have to go beyond “monitoring technological resourc-
es for the privileged”15,16. Therefore, he was searching 
for a broader context.
Potter’s view of “global bioethics”, an idea that now-
adays could be explained by the concept of “sustainable 
development” (although still too narrow to encompass 
Potter’s entire idea), has become more relevant than 
ever. Therefore, it is reasonable and important to re-
member him here, primarily through his own thoughts 
from 1998: “The original theory of bioethics was the 
idea that long-term survival of the human race in a 
decent and sustainable civilization requires developing 
and maintaining an ethical system. Such a system is 
“global bioethics”, based on the deliberations and con-
clusions imposed by empirical findings from all sci-
ences, but especially from biological knowledge... This 
proposed ethical system forms even today the core of 
the “bioethical bridge” with its expansion into “glob-
al bioethics”, in which the bridging function requires 
connection of medical ethics and the environment at 
the global level so as to preserve human survival”15,16.
By finding a foothold in the legacy of professor Aldo 
Leopold, who advocated the “Earth ethics”, warning 
of the impending environmental crisis, looking at it as 
a “failure to carry out further economic activities on 
the ethical basis”28, Potter developed the concept of 
“environmental ethics”. Inspired by Leopold’s theses, 
in 1988 Potter wrote a new book, “Global Bioethics: 
Building on the Leopold Legacy”, in which he pro-
posed a definition of global bioethics as a “biology 
combined with diverse humanistic knowledge forging 
a science that sets a system of medical and environ-
* The so-called “European bioethical school” should also be noted, 
i.e. development of the idea that the word and concept “bioethics” 
has in fact European roots. It emerged from the pen of Fritz Jahr, 
who used it in 1927 in the journal Cosmos describing “an overvi-
ew of ethical relationships of man to animals and plants”22-24. 
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mental priorities for acceptable survival”29. Here also, 
like a common thread, he set out a vision of bioethics 
as a bridge between natural and human sciences in 
the service of achieving health for people all over the 
world and environmental protection. “... In fact, I have 
since 1970 lobbied for a “bridge bioethics”, which was 
the vision of connecting “two cultures” – natural and 
human sciences, or more precisely, biological knowl-
edge and ethics (bio-ethics), believing that in this 
way a bridge to the future should be built. (The word 
“bridge” is a metaphor for the intention to encourage 
the survival of humankind and the intention to link 
science and philosophy). But as we enter the 21st cen-
tury and the third millennium, “bridge bioethics” is 
required to deal with not only the “two cultures”, but 
also with a host of ethical branches... Today, after six 
decades of experience, I am arguing that “global bio-
ethics”, as well as new scientific ethics, is necessary for 
long-term survival of humankind...”15,16.
Personalized Medicine and Public Health Ethics 
“Medical ethics, which is now being practiced un-
der the name of bioethics, is a short-term tactic; in 
fact it is a clinical ethics, which deals with dilemmas 
faced by doctors, their patients and those who care for 
patients. Global bioethics, in turn, calls upon medical 
ethicists to consider the basic meaning of bioethics and 
to expand their thinking and actions to global public 
health problems. Medical ethicists are obliged to con-
sider not only the everyday clinical decisions, but also 
long-term consequences of action they recommend, 
or fail to consider. Restructured medical ethics would 
be associated with the long-term environmental eth-
ics and its short-term guidelines, and would connect 
with it forming thereby the second phase of “bridge 
bioethics”, i.e. “global bioethics”, a system whose task 
is to define and develop an ethics for sustainable long-
term survival of humankind”15,16.
It is simply bewildering how current Potter’s global 
bioethics is, especially if placed in the new focus of bio-
ethical interest, and that is the ethics of public health, 
which is yet in its developmental stage, although the 
biggest bioethical “scandals” are decades old and be-
long precisely to the context of public health.
When thinking about current events and perspec-
tives of public health ethics, we cannot bypass the idea 
of  “personalized medicine”, which in itself basically 
represents the closest presentation of clinical (bio)eth-
ics – medicine and its ethics aimed at the individual30. 
When opposing the idea of  such “personalized bioeth-
ics” to Potter’s (almost public health) idea of  ”global 
bioethics” as a “global survival”31, Donna L. Dickenson 
must be emphasized as the greatest contemporary critic 
of “ME-medicine”.** In her “critique of personalized 
medicine”, Dickenson, in fact, considered one of the 
fundamental problems faced by Potter’s (public health) 
global bioethics, which is the relationship between pri-
vate and public, i.e. personal and social, whose denomi-
nator is the reallocation of resources in the health sector. 
Personalized medicine is the kind of treatment adapted 
to each patient, i.e. precisely this treatment custom-
ized precisely for this patient, precisely for this disease 
and right now, while public health is a set of activities 
which would enable reaching the highest possible level 
of health for every individual, every citizen30,33. Today, 
both colloquially and in “serious” literature, two popu-
lar names for these two approaches are pointed out, i.e. 
“ME medicine” or “WE medicine”, which were popu-
larized by Dickenson. She drew particular attention in 
2013 with the release of the book “ME Medicine vs. 
WE Medicine: Reclaiming Technology for the Com-
mon Good”34. In the book and in other recent works, 
as well as in numerous appearances in interviews, blog 
posts, etc., Dickenson indicates fundamental differ-
ences between ME and WE medicine, which is why 
they “must” stand in conflict:
•	 in	the	center	of	observation	of	ME	medicine	is	the	
individual as the user of the health care system, 
as well as his right to an (informed) choice of the 
most optimal form of health care, and based on the 
bioethical principle of autonomy;
•	 on	the	other	side	is	the	public	health	approach	that	
focuses on the individual as a member of the (nar-
rower or wider) community, which consists of the 
society at the national, regional, European, global 
level; therefore the bioethical framework of obser-
** Dickenson is well known by those bioethicists who have, for 
example, dealt with the analysis of the three fundamental, star-
ting concepts of the European bioethics, which are defined as 
deontological, liberal and model of social welfare. Her work may 
help in understanding the way in which medical-ethical decisions 
are made in everyday communication of health professionals and 
patients in certain socio-cultural and economic contexts32.
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vation is based on the principles of justice (i.e. on 
social equality before the health care system), and 
beneficence that, in the context of public health, 
is redefined through the concept of social well-
being34-37.
The key problem or concern is articulated precisely 
through the philosophy of personalized medicine, 
which is according to Dickenson in diametrical op-
position to the philosophy and the vision of public 
health: redistribution of resources at the expense of 
financing preventive public health interventions at the 
global level. Thereby the question of (pre)conditions 
is raised regarding the application of the existing, 
current technology, and the legitimacy of the need to 
invest in new technologies. Dickenson believes that 
special attention should be paid to understanding the 
social/societal and economic context. Striking a bal-
ance between the individual and the general-social 
well-being in health care has become a key issue35,36!
Potter clearly articulates how today (medical, 
clinical, public health) ethicists “must cooperate with 
social ethicists and require health care measures for 
the downtrodden in their home countries and in de-
veloping countries, where poverty is linked to AIDS, 
malaria, parasitic diseases and tuberculosis...”15,16. 
And precisely in this attempt to consolidate, on the 
one hand, the idea of a personalized medicine, which 
is encamped in translational medicine (“from bench 
to bedside”)38, where expensive cures are created for 
“the chosen ones” (the issue here is what are the cri-
teria and are there any acceptable criteria) with the 
idea of a social well-being, we once again reach to 
bioethics as a bridge between these, at first glance, 
opposing ideas. Precisely global bioethics, governed 
by the idea of  health care equity, provides a context 
for the so called “socialization” of personalized medi-
cine, i.e. approaching the philosophy of “personalized 
medicine for public benefit”... One can therefore say 
that personalized medicine, as seen by the European 
Science Foundation, is very “Potter-like” globally ori-
ented because it stands for:
•	 adapting	health	care	systems	to	individual	differ-
ences of their users, as much as possible, and at all 
levels of the process (from prevention to diagnosis 
and treatment to various follow-up procedures);
•	 a	pro-active	and	preventive	approach	to	health	and	
(social) welfare of all (European) citizens; and
•	 profound	implications	above	and	beyond	the	health	
care system (social reactions!)39.
In fact, any attempt to redefine the approach to 
and the understanding of the health care system, by 
its definition, affects the entire society39. Global bio-
ethics as a framework therefore provides that the idea 
of personalized medicine appears in the position of 
public health ethics, with the aim that the apposition 
of “personalized” or “public” becomes irrelevant and 
in order for that which is important to be highlighted. 
And that is the right to preserve health, i.e. to use 
Potter’s definition of the right to “an acceptable sur-
vival” (in the context of the overall ecosystem – global 
survival)31!
Instead of a Conclusion
In 1998, Potter said: “As I am entering the dusk of 
my life, I feel that bioethics has reached the thresh-
old of a new time that goes beyond anything I could 
have imagined and developed. By entering the era of 
the third millennium, we are becoming increasingly 
aware of the dilemma that places before us an expo-
nential increase in knowledge without an increase in 
the wisdom required to manage it”15,16.
Let us recall that V.R. Potter II always viewed 
bioethics as a new discipline, a “new medical ethics” 
which would combine knowledge and deliberation, 
a dynamic approach to ongoing search of the hu-
man race for wisdom, i.e. knowledge on how to use 
knowledge for human survival and improvement of 
the quality of life.
Bioethics is the science about the use of science. 
It is the ethical supervisor of science. Without such 
a supervisor, science can escape human control and 
become “dangerous knowledge”. Bioethics should, 
therefore, represent a new scientific ethics that con-
nects humility, responsibility and ability; a science 
which is interdisciplinary, cross-cultural and global, 
and that exalts the meaning of humanity. It perceives 
the man’s well-being in the context of respect for na-
ture, and as such should become a kind of a “science 
of survival”8,15,16,40.
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Sažetak
AKTUALNO SAGLEDAVANJE POTTEROVE GLOBALNE BIOETIKE KAO MOSTA IZMEĐU 
KLINIČKE (PERSONALIZIRANE) I JAVNOZDRAVSTVENE ETIKE
I. Sorta-Bilajac Turina, M. Brkljačić, C. Grgas-Bile, D. Gajski, A. Racz i T. Čengić
U kontekstu suvremenih znanstveno-tehnoloških dostignuća u biomedicini i zdravstvu i potencijalnih posljedica pri-
mjene za čovjeka i okoliš na površinu isplivava Potterov globalni bioetički koncept. Aktualizirajući izvorne Potterove misli 
na pojedine bioetičke teme ukazuje se na svevremenost dviju njegovih knjiga koje i danas predstavljaju okosnicu svjetske 
bioetičke literure: “Bioethics – Bridge to the Future” te “Global Bioethics: Building on the Leopold Legacy”. Potterova 
globalna bioetika danas se legitimno može promatrati kao most između kliničke personalizirane etike s jedne strane od-
nosno etike javnog zdravstva s druge. 
Ključne riječi: Bioetika – povijest; Etika, klinička; Potter VR; Personalizirana medicina; Javno zdravstvo
